SLU-PP-332 is a synthetic small molecule developed as an ERR agonist within mitochondrial and metabolic regulation research. It has been studied in the context of oxidative metabolism, endurance-associated signaling, mitochondrial biogenesis, and skeletal muscle energy utilization in preclinical models. Its activity at estrogen-related receptor pathways places it within a distinct category of non-peptide metabolic compounds focused on transcriptional regulation rather than incretin or hormonal signaling. Lyophilized powder, 3mL vial. Sold at 10mg per vial. For research use only.